Shaping Success in
Research Ethics


Since 1991, TRAFALGAR ETHICS BOARD (TEB) has continued to expand its Client base of major Pharmaceutical Sponsors, Contract Research Organizations, Medical Device Manufacturers and Independent Investigators. TEB's reputation in bioethics continues to strengthen through Responsiveness, Focus on Customer Success, and Total Commitment to Study Participant Protection.

BASED IN CANADA, TEB provides Central and Community Ethics Review and Monitoring services to the “Who's Who” of International Sponsors. Working smoothly within continuously evolving International Study structures, TEB has evolved its own processes to meet the demand for streamlined Studies, resulting in faster-to-market, properly evaluated pharmaceuticals and devices, to increase human wellbeing.

FDA Issues Final Guidance on IRB Continuing Review
6 Mar 12
FDA has issued the final guidance, "IRB Continuing Review after Clinical Investigation Approval." This guidance is intended to assist  more >